Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are…
NEW YORK CITY, NY / ACCESS Newswire / November 26, 2025 / Is the future of weight loss found in…
CHARLOTTE, NC / ACCESS Newswire / November 26, 2025 / First Care Medical Clinic is proud to announce its recognition…
Two December programs provide education and support for those struggling emotionallyCHICAGO, Nov. 26, 2025 /PRNewswire/ -- While the holiday season is…
Student Mental Health Leader Ranks #2 in New England NATICK, Mass., Nov. 26, 2025 /PRNewswire/ -- Uwill, the leading mental health…
Approved multicenter study sponsored by Sheba Medical Center to compare group and individual MDMA-assisted therapy for 168 patients experiencing trauma-related…
MIAMI, Nov. 25, 2025 /PRNewswire/ -- On Saturday, November 8, 2025, the Community-Police Relations Foundation (CPR Foundation) hosted its Third Annual…
Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and managementJoint research to enhance dementia…
New resource provides clear guidance on insurance, financing, grants, and medication savings programs to make family building more accessibleNORWALK, Conn.,…
BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…